Online gift

Laureates of the Charcot Funds

Help us Make a gift or leave a legacy

Jury of the Charcot Fund 2024

for the Belgian Charcot Foundation

Prof. Dr. Christian Sindic (President), Professor Emeritus of UCLouvain

for the scientific committee of the Belgian Charcot Foundation

Dr Pierrette Seeldrayers, Neurologist.
Prof. Dr. Alain Maertens de Noordhout, Head of Department of Neurology, CHR Citadelle, Liège.
Prof. Dr Alex Michotte, Head of Department of Neurology, UZ Brussels.
Prof. Vincent van Pesch, Deputy head of Department of Neurology, Cliniques St Luc, Brussels

 

Charcot Fund 2024 : € 303.360 For multiple sclerosis fundamental research

Grant

€ 40,000 / 1 year

Prof. Bénédicte Dubois and Prof. Patrick Matthys

The project

The role of natural killer cells in the brain of MS patients
KULeuven - Laboratory for Neuroimmunology
Detail of the grant

Grant

€32,500 / 2 years

Dr Sam Vanherle, Prof. Alan Remaley and Dr Mart Reimund

The project

Next-generation peptides as a therapeutic tool to promote remyelination
UHasselt - Biomedical Research Institute
Detail of the grant

Grant

€40,000 / 2 years

Prof. Jeroen Bogie, Prof. Dante Neculai and Mr Jeroen Guns

The project

Harnessing palmitoylation to attenuate neuroinflammation and boost remyelination in multiple sclerosis patients
UHasselt - Biomedical Research Institute, Medical Biochemistry and Immunology lab
Detail of the grant

Grant

€52,000 / 2 years

Prof. Lidia Yshii

The project

Role of amphiregulin in multiple sclerosis
KULeuven - Laboratory of Neuroinflammation
Detail of the grant

Grant

€39,360 / 2 years

Dr Leen Slaets, Prof. Niels Hellings and Prof. Jeroen Bogie

The project

Cellular Aging: An Underestimated Player in the Pathology of MS
UHasselt - BIOMED
Detail of the grant

Grant

€59,750 / 2 years

Prof. Jerome Hendriks, Dr Sanne Verberk and Prof. Johan Swinnen

The project

Phagocyte energy metabolism as target to induce remyelination in MS
UHasselt and KULeuven
Detail of the grant

Grant

€ 39,750 / 2 years

Prof. Giulio Muccioli

The project

Targeting the G-protein coupled receptor 183 in the context of multiple sclerosis – a preclinical proof-of concept
UCLouvain - Louvain Drug Research Institute
Detail of the grant